Skip to main content

Table 1 Baseline characteristics between follow-up and loss to follow-up at 3 months or 12 months

From: Can acute clinical outcomes predict health-related quality of life after stroke: a one-year prospective study of stroke survivors

 

3 months

p value

12 months

p value

Follow-up

Loss to follow-up

Follow-up

Loss to follow-up

N = 380

N = 218

N = 322

N = 276

N (%)

N (%)

N (%)

N (%)

Age, mean (sd)

62.3 (10.6)

62.0 (11.0)

0.758

62.1 (10.6)

62.4 (11.0)

0.718

Gender

  

0.731

  

0.273

 Male

251 (66.0)

147 (67.4)

 

208 (64.6)

190 (68.8)

 

 Female

129 (34.0)

71 (32.6)

 

114 (35.4)

86 (31.2)

 

Ethnicity

  

0.130

  

0.452

 Chinese

249 (65.5)

159 (72.9)

 

214 (66.5)

194 (70.3)

 

 Malay

94 (24.7)

39 (17.9)

 

78 (24.2)

55 (19.9)

 

 Indian and others

37 (9.8)

20 (9.2)

 

30 (9.3)

27 (9.8)

 

Marital status

  

0.001

  

0.049

 Single

38 (10.0)

36 (16.5)

 

31 (9.6)

43 (15.6)

 

 Married

282 (74.2)

134 (61.5)

 

239 (74.2)

177 (64.1)

 

 Separated/ Divorced

14 (3.7)

22 (10.1)

 

17 (5.3)

19 (6.9)

 

 Widowed

46 (12.1)

26 (11.9)

 

35 (10.9)

37 (13.4)

 

Primary caregiver

  

0.186

  

0.170

 Spouse

204 (54.0)

98 (45.4)

 

175 (54.5)

127 (46.5)

 

 Child

92 (24.3)

55 (25.5)

 

75 (23.4)

72 (26.4)

 

 Sibling

19 (5.0)

19 (8.8)

 

21 (6.5)

17 (6.2)

 

 Maid/ others

21 (5.6)

15 (6.9)

 

20 (6.2)

16 (5.9)

 

 None

42 (11.1)

29 (13.4)

 

30 (9.4)

41 (15.0)

 

Survey mode at baseline

  

0.721

  

0.766

 Stroke patient

358 (94.2)

205 (94.9)

 

305 (94.7)

258 (94.2)

 

 Primary caregiver

22 (5.8)

11 (5.1)

 

17 (5.3)

16 (5.8)

 

Subtype of stroke

  

0.414

  

0.876

 Infarct (Ischemic)

341 (89.7)

190 (87.6)

 

287 (89.1)

244 (88.7)

 

 Haemorrhage/ both

39 (10.3)

27 (12.4)

 

35 (10.9)

31 (11.3)

 

Episode of stroke

  

0.809

  

0.637

 First stroke

309 (81.3)

179 (82.1)

 

265 (82.3)

223 (80.8)

 

 Recurrent stroke

71 (18.7)

39 (17.9)

 

57 (17.7)

53 (19.2)

 

CCI, mean (sd)

5.00 (1.70)

4.85 (1.87)

0.320

4.95 (1.73)

4.95 (1.82)

0.989

EQ index value at baseline, mean (sd)

0.83 (0.26)

0.84 (0.25)

0.577

0.83 (0.27)

0.84 (0.25)

0.489

CES-D, mean (sd)

6.32 (5.48)

6.90 (5.48)

0.207

6.56 (5.41)

6.50 (5.57)

0.901

Shah-mBI, mean (sd)

71.79 (30.62)

71.75 (31.21)

0.986

70.38 (31.45)

73.40 (30.03)

0.232

NIHSS, mean (sd)

4.74 (4.57)

4.51 (4.50)

0.547

4.57 (4.42)

4.75 (4.69)

0.626

MMSE, mean (sd)

23.23 (6.26)

22.67 (6.39)

0.295

23.28 (6.21)

22.73 (6.42)

0.290

FAB, mean (sd)

13.45 (4.51)

13.65 (4.32)

0.594

13.81 (4.27)

13.19 (4.60)

0.087

mRS, mean (sd)

2.65 (1.33)

2.49 (1.41)

0.151

2.61 (1.37)

2.58 (1.36)

0.792

mRS

  

0.207

  

0.332

 No symptoms at all

8 (2.1)

11 (5.0)

 

7 (2.2)

12 (4.4)

 

 No significant disability

104 (27.4)

66 (30.3)

 

98 (30.4)

72 (26.1)

 

 Slight disability

54 (14.2)

32 (14.7)

 

43 (13.4)

43 (15.6)

 

 Moderate disability

72 (18.9)

29 (13.3)

 

53 (16.5)

48 (17.4)

 

 Moderately severe disability

130 (34.2)

75 (34.4)

 

109 (33.8)

96 (34.8)

 

 Severe disability

12 (3.2)

5 (2.3)

 

12 (3.7)

5 (1.8)

 
  1. sd: standard deviation; CCI: Charlson Comorbidities Index; CES-D: Center of Epidemiologic Studies Depression Scale; Shah-mBI: Shah-modified Barthel Index; NIHSS: National Institute of Health Stroke Scale; MMSE: Mini-Mental State Examination; FAB: Frontal Battery Assessment; mRS: Modified Rankin Scale